Cardiac sarcoidosis: A comprehensive review

Archives of Medical Science

Volumn 7, Issue 4, 2011, Pages 546-554

  Sekhri, Vishal ^a   Sanal, Shireen ^a   DeLorenzo, Lawrence J ^a   Aronow, Wilbert S ^a   Maguire, George P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cardiac sarcoidosis; Noncaseating granulomas; Sarcoidosis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 2; METHOTREXATE;

ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR MAGNETIC RESONANCE; CD4+ T LYMPHOCYTE; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; HEART TRANSPLANTATION; HEART VENTRICLE ANEURYSM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PERICARDIAL EFFUSION; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 80052578877     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.24118     Document Type: Review

References (62)

1. Benjamin AR, Marcie M, John P, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-41.
2. Lee LS, Rose CS, Maier LA. Sarcoidosis N Engl J Med 1997; 336: 1224-34.
3. Bernstein M, Konzelmann FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929; 44: 721-34.
4. Silverman KJ, Hutchins GM, Buckley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-11.
5. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005; 185: 110-5.
6. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278: 455-69.
7. Tachibana T, Iwai K, Takemura T. Study on the cause of death in patients with sarcoidosis in Japan [abstract]. XII World Congress on Sarcoidosis, Kyoto, Japan, September 8, 1991.
8. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-30.
9. DuBois RM, Goh N, McGrath D, et al. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Int Med 2003; 253: 4-17.
10. Tercelj M, Rott T, Rylander R. Antifungal treatment in Sarcoidosis - a pilot intervention trial. Resp Med 2007; 101: 774-8.
11. Doughan AR, Williams BR. Cardiac Sarcoidosis. Heart 2006; 92: 282-8.
12. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63: 86-108.
13. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-9.
14. Naruse TK, Matsuzawa Y, Ota M, et al. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 2000; 56: 52-7.
15. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54: 191-3.
16. Sharma OP. Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 2003; 123: 18-9.
17. Fleming HA. Sarcoid heart disease. Br Heart J 1974; 36: 54-68.
18. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134: 382-6.
19. Sekiguchi M, Numao Y, Imai M, et al. Clinical and histological profile of sarcoidosis of the heart and acute idiopathic mypcarditis. Concepts through a study employing endomycoardial biopsy. I Sarcoidosis. Jpn Circ J 1980; 44: 249-63.
20. Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004; 27: 217-22.
21. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
22. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 15: 537-40.
23. Garrett J, O'Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J 1984; 107: 394.
24. Pesola G, Teirstein AS, Goldman M. Sarcoidosis presenting with pericardial effusion. Sarcoidosis 1987; 4: 42-4.
25. Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985; 110: 116-22.
26. Lull RJ, Dunn BE, Gregoratos G, et al. Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol 1972; 30: 282-7.
27. Jain A, Starek PJ, Delany DL. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol 1990; 13: 738-40.
28. Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003; 124: 922-8.
29. Handa T, Uozato H, Higa R, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006; 129: 1246-52.
30. Preston I, Klinger JR, Landzberg MJ, et al. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest 2001; 120: 866-72.
31. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies Am Heart J 1999; 138: 299-302.
32. Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idio pathic giant cell myocarditis. Am J Cardiol 2003; 41: 322-8.
33. Stein E, Jacler I, Stimmel B, et al. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J 1973; 86: 474-7.
34. Schuster EH, Conrad G, Morris F, et al. Systemic sarcoidosis and electrocardiographic conduction abnormalities. Chest 1980; 78: 601-4.
35. Thunell M, Bjerle P, Stjemberg N. ECG abnormalities in patients with sarcoidosis. Acta Med Scand 1963; 213: 115-8.
36. Suzuki T, Tsugiyasu K, Kubata S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994; 106: 1021-4.
37. Uyarel H, Uslu N, Okmen E, et al. QT dispersion in sarcoidosis. Chest 2005; 128: 2619-25.
38. Tatli E, Aktoz M, Gul C, et al. Does carvedilol therapy reduce QT dispersion in patients with heart failure? Arch Med Sci 2008; 4: 404-8.
39. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine 2004; 83: 315-34.
40. Skold CM, Larsen FF, Rasmussen E, et al. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med 2002; 252: 465-71.
41. Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a noninvasive method with ultrasonic tissue characterization. Heart 2004; 90: 1275-80.
42. Haywood LJ, Sharma OP, Siegel ME. Detection of myocardial sarcoidosis by thallium-201 imaging. J Natl Med Assoc 1983; 63: 478-82.
43. Fields CL, Ossorio MA, Roy TM, et al. Thallium 201 scintigraphy in the diagnosis the management of myocardial sarcoidosis. South Med J 1990; 83: 339-42.
44. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial defects in patients with sarcoidosis. Am J Med 1988; 85: 189-93.
45. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium 201 and gallium 67 in cardiac sarcoidosis. Chest 1995; 107: 330-4.
46. Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual 67Ga and 99mTc-sestamibi single- photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest 2004; 26: 1372-6.
47. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features AJR Am J Roentgenol 2005; 184: 249-54.
48. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002; 26: 762-7.
49. Serra JJ, Monte GU, Mello ES, et al. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation 2003; 107: 188-9.
50. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000; 55: 323-5.
51. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005; 185: 110-5.
52. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005; 28: 328-8.
53. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003; 44: 1030-6.
54. Williams SG, Barker D, Goldspink DF, et al. A reappraisal of concepts in heart failure: central role of cardiac power reserve. Arch Med Sci 2005; 1: 65-74.
55. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.
56. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005; 128: 30-5.
57. Lower EE, Baughman RP. The use of low dose metho - trexate in refractory sarcoidosis. Am J Med Sci 1990; 299: 153-7.
58. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 60-6.
59. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 70-4.
60. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987; 6: 244-50.
61. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorder (WASOG) adopted by The ATS Board of Directors and the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
62. Burke WM, Keogh A, Maloney PJ, et al. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990; 336:1579.